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Abstract
It is generally accepted that CD8 T cells play the key role to maintain HSV-1 latency in trigeminal ganglia of ocularly infected
mice. Yet, comparably little is known about the role of innate immunity in establishment of viral latency. In the current
study, we investigated whether CD8a DCs impact HSV-1 latency by examining latency in the trigeminal ganglia (TG) of wild-
type (WT) C57BL/6 versus CD8a2/2 (lack functional CD8 T cells and CD8a+ DCs), CD8b2/2 (have functional CD8a+ T cells and
CD8a+ DCs), and b2m2/2 (lack functional CD8 T cells but have CD8a+ DCs) mice as well as BXH2 (have functional CD8 T cells
but lack CD8a+ DCs) versus WT C3H (have functional CD8a T cells and CD8a+ DCs) mice. We also determined whether the
phenotype of CD8a2/2 and BXH2 mice could be restored to that of WT mice by adoptive transfer of WT CD8+ T cells or
bone marrow (BM) derived CD8a+ DCs. Our results clearly demonstrate that CD8a DCs, rather than CD8 T cells, are
responsible for enhanced viral latency and recurrences.
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Introduction
HSV-1 infections are among the most frequent infections in the
U.S. In addition to eye disease, HSV-1 can cause recurring
orolabial lesions, pharyngitis, genital lesions, and less commonly,
encephalitis [1–3]. It is estimated that 70–90% of the adult
population in the U.S. has antibodies to HSV-1 and/or HSV-2,
with about 25% showing clinical symptoms [4–6]. At various times
throughout the life of the latently-infected individual, the virus
may reactivate, travel back to the original site of infection and
cause recurrent disease [2,3]. Episodic recurrences2not primary
infection2are the causative mechanism of corneal scarring (CS),
which is also broadly referred to as herpes stromal keratitis (HSK)
[7–10]. Despite the seriousness of recurrent ocular herpes, no drug
has been FDA approved that prevents ocular recurrences. There is
a critical need to understand the mechanism(s) behind HSV-1
latency so that effective methods for prevention and control of
serious HSV-1-induced ocular syndromes can be devised.
Previously, it was shown that CD8 T cells infiltrate trigeminal
ganglia (TG) at the time of HSV-1 latency establishment, where
they have been hypothesized to inhibit reactivation from latency
[11]. During latency, a subset of CD8 T cells remain in direct
contact with infected neurons [12]. These cells can block HSV-1
reactivation from latency in ex vivo cultures of TG from latently-
infected mice [11,12]. We previously demonstrated that mice
latently infected with wild-type (WT) HSV-1 have increased
Latency-Associated Transcript (LAT) mRNA, and both increased
CD8 and greater abundance of PD-1 mRNAs in their TGs,
relative to mice latently infected with LAT deficient virus [13,14].
More recently, our group found significantly decreased HSV-1
latency in PD-12/2 and PD-L12/2 mice compared to WT or PD-
L22/2 mice [13]. Further, we reported that mice depleted of their
DCs by diphtheria toxin had lower levels of latency than mock-
depleted control counterparts, and that myeloid DCs regulated
this process [15]. Collectively, these studies suggest that DCs have
a previously unappreciated function to modulate HSV-1 latency.
While the potential role of LAT in this process is unclear, greater
LAT production may result in increased DC infectivity, less anti-
viral responses, and thus greater propensity for latency.
In this report, we examined latency in TG of WT versus
CD8a2/2 and BXH2 mice, both of which do not have functional
CD8a+ DCs [16,17]; while CD8a2/2 mice lack and BXH2 mice
have CD8 T cells. Additionally, b2m2/2 (lack functional CD8 T
cells) and CD8b2/2 (have functional CD8 T cells) mice that have
CD8a+ DCs were utilized. We determined if DCs from these mice
behave differently following infection with LAT(+) versus LAT(2)
viruses, and whether the phenotype of CD8a2/2 mice could be
restored to that of WT mice by adoptive transfers of WT CD8+ T
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Figure 1. Quantitation of gB DNA and LAT RNA in trigeminal ganglia of HSV-1 latently-infected mice. Wild-type (WT) C57BL/6, b2m
2/2,
or CD8a2/2 mice were ocularly-infected with HSV-1 strain McKrae (LAT(+)). On day 28 PI, TG were harvested from latently infected mice. Quantitative
PCR and RT-PCR was performed on each individual mouse TG. In each experiment, an estimated relative copy number of the HSV-1 gB (for viral DNA)
and LAT (for viral RNA) were calculated using standard curves generated from pGem-gB1 and pGem5317, respectively. Briefly, DNA template was
serially diluted 10-fold such that 5 ml contained from 103 to 1011 copies of gB, then subjected to TaqMan PCR with the same set of primers. By
comparing the normalized threshold cycle of each sample to the threshold cycle of the standard, the copy number for each reaction was determined.
Role of CD8a DCs in HSV-1 Latency
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cells or bone marrow (BM) derived CD8a DCs. These studies
point to a key role for CD8a+ DCs in establishment and
maintenance of HSV-1 latency.
Materials and Methods
Ethics Statement
All animal procedures were performed in strict accordance with
the Association for Research in Vision and Ophthalmology
Statement for the Use of Animals in Ophthalmic and Vision
Research and the NIH Guide for the Care and Use of Laboratory Animals
(ISBN 0-309-05377-3). Animal research protocol was approved by
the Institutional Animal Care and Use Committee of Cedars-Sinai
Medical Center.
Virus and Mice
Plaque-purified virulent HSV-1 strains McKrae and avirulent
KOS were grown in rabbit skin (RS) cell monolayers in minimal
essential medium (MEM) containing 5% fetal calf serum (FCS), as
described previously [18]. RS (rabbit skin) cells (from Steven L
Wechsler) was described previously [19].
WT C57BL/6, C57BL/6-CD8a2/2, C57BL/6-b2m
2/2,
C57BL/6-DTR, C57BL/6-GFP, BXH2/TyJ and C3H/HEJ
mice were purchased from Jackson Laboratories. C57BL/6-
CD8b2/2 mice have been reported previously [20] and were
bred in-house.
Ocular Infection
Mice on the C57BL/6 background were infected ocularly with
26105 PFU per eye of HSV-1 strain McKrae, while BXH2/TyJ
and C3H/HEJ mice were ocularly infected with 26103 of
McKrae or 26105 PFU/eye of avirulent HSV-1 strain KOS
due to their susceptibility to infection with higher PFU of HSV-1
strain McKrae. Each virus was suspended in 2 ml of tissue culture
medium and administered as an eye drop without prior corneal
scarification. Survival data in different mouse strains following
infection with various PFU of HSV-1 strain McKrae are shown in
Supplementary Table 1.
DC Culture
Six week-old mice were used as a source of bone marrow (BM)
for the generation of mouse DCs in culture. BM cells were isolated
by flushing femurs with PBS. Pelleted cells were briefly
resuspended in red blood lysing buffer (Sigma) to lyse red blood
cells and stabilized by adding complete medium (RPMI 1640,
10% fetal bovine serum, 100 U/ml penicillin, 100 mg/ml strep-
tomycin, 2 mM L-glutamine). The cells were centrifuged and
resuspended in complete medium supplemented with GM-CSF
(100 ng/ml; Peprotech, NJ) to enhance replication of DCs [21,22].
Afterwards, cells were plated in non-tissue culture plastic Petri
dishes (1 bone per 10 cm dish) for 5 days at 37uC with CO2.
Infection of DCs
Monolayers of DCs from WT, b2m
2/2, CD8a2/2, or
CD8b2/2 were infected with 1 PFU/cell of HSV-1 strains
McKrae. One hr after infection at 37uC, virus was removed and
the infected cells were washed three times with fresh medium and
growth medium was replaced. At 24 hr post infection, infected
GAPDH expression was used to normalize the relative expression of viral (gB) DNA and LAT RNA in the TG. Each data point represents the mean 6
SEM from 20 TGs for WT and 18 TGs for b2m
2/2 or CD8a2/2 mice from two separate experiments. Panels: A) gB DNA; and B) LAT RNA (the Y-scale for
LAT in CD8a2/2 mice TG is different than the Y-scale for WT and b2m
2/2 mice).
doi:10.1371/journal.pone.0093444.g001
Figure 2. Quantitation of HSV-1 latency in CD8b2/2 infected
mice. Wild-type (WT) C57BL/6 and CD8b2/2 mice were infected as
described in Materials and Methods. Twenty-eight days PI, TGs from
infected mice were harvested and quantitative PCR and RT-PCR were
performed on each individual mouse TG. Each data point for gB DNA
represents the mean 6 SEM from 24 TGs. For LAT RNA, each data point
represents 22 TGs for CD8b2/2 and 18 TGs for WT mice from two
separate experiments. Panels: A) gB DNA; and B) LAT RNA.
doi:10.1371/journal.pone.0093444.g002
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DCs monolayers were harvested and the presence of gB transcript
was determined by qRT-PCR.
Adoptive Transfer of BM or CD8a DCs to Recipient Mice
BM from C57BL/6-GFP mice was isolated and each recipient
CD8a2/2 mouse received BM from one donor mouse. We
compared Intravenous (IV) and Intraperitoneal injection (IP)
routes of BM transfer and found that IV transfer was more
efficient than IP; therefore, all the experiments described here are
based on IV transfer of BM. Two weeks post-transfer, the CD8a2/
2 recipient mice were ocularly infected with HSV-1 strain
McKrae. TG, BM, spleen, and thymus from recipient mice were
isolated on the same day as ocular infection, and 14 and 28 days
post ocular infection. Tissues were used for flow cytometry and
IHC. TG from infected mice were also isolated for detection of
LAT RNA and gB DNA on day 28 PI. For transfer to BXH2
mice, cultured DCs from C3H/HEJ mice were grown as above,
harvested on day 5, and CD8a DCs were isolated by two cycles of
positive selection per the manufacturer’s protocol (Miltenyi Biotec,
Auburn CA). The purity of isolated CD8a DCs was more than
97% as confirmed by FACS analysis using anti-CD11c/anti-
CD8a antibodies. Each recipient BXH2 mouse received CD8a
DCs from one donor mouse and two weeks post-transfer, the
recipient mice were ocularly infected with HSV-1 strain KOS. TG
from infected mice were also isolated for detection of LAT RNA
on day 28 PI.
Adoptive Transfer of CD8 T Cells
Donor WT C57BL/6-GFP mouse spleens were pooled, and
single-cell suspensions were prepared as described previously [23].
CD8 T cells were isolated using magnetic beads as described by
the manufacturer (Miltenyi Biotec). After two cycles of purifica-
tion, the purity of isolated CD8 T cells was 97% as confirmed by
FACS analysis using anti-CD3/anti-CD8a antibodies. Each
Figure 3. IHC of DCs isolated from different knockout of mice. BM-derived DCs from WT, b2m
2/2, CD8a2/2, and CD8b2/2mice were isolated
and grown on Lab-Tex chamber slides. At 24 hr post culture, DCs were fixed, stained with anti-CD11c/anti-CD4, CD11c/anti-CD8a, or CD11c/anti-
CD8b antibodies followed by incubation with relevant secondary antibody to each primary antibody as described in Materials and Methods. DAPI is
shown as a nuclear counter-stain. A (WT DCs). Upper panels from left to right DAPI, CD11c (FITC), CD4 (TRITC), Merge; middle panels: from left to right
DAPI, CD11c (FITC), CD8a (TRITC), Merge and bottom panels: from left to right DAPI, CD11c (FITC), CD8b (TRITC), Merge; B (b2m
2/2 DCs). Upper
panels from left to right DAPI, CD11c (FITC), CD4 (TRITC), Merge; middle panels: from left to right DAPI, CD11c (FITC), CD8a (TRITC), Merge, and
bottom panels: from left to right DAPI, CD11c (FITC), CD8b (TRITC), Merge; C (CD8a2/2 DCs). Upper panels from left to right DAPI, CD11c (FITC), CD4
(TRITC), Merge; middle panels: from left to right DAPI, CD11c (FITC), CD8a (TRITC), Merge, and bottom panels: from left to right DAPI, CD11c (FITC),
CD8b (TRITC), Merge; and D (CD8b2/2 DCs). Upper panels from left to right DAPI, CD11c (FITC), CD4 (TRITC), Merge; middle panels: from left to right
DAPI, CD11c (FITC), CD8a (TRITC), Merge, and bottom panels: from left to right DAPI, CD11c (FITC), CD8b (TRITC), Merge.
doi:10.1371/journal.pone.0093444.g003
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recipient mouse was injected once with CD8+ T cells from one
donor mouse in 300 ml of MEM intraperitoneally. The control
mice received 300 ml MEM alone. We compared IV and IP routes
of CD8+ T cells transfer and detected no differences; therefore, all
the experiments described here are based on IP transfer of CD8 T
cells. The recipient and control mice were infected ocularly with
strain McKrae 2 weeks after transfer of the CD8+ T cells. Presence
of CD8 T cells in the spleen, thymus, BM, and TG of recipient
mice was determined by IHC and flow cytometry before ocular
infection, and at weeks 2 and 4 PI. TG from infected mice were
also isolated for detection of LAT RNA and gB DNA on day 28
PI.
Confocal Microscopy and Image Analysis
DCs isolated from different strains of mice were grown on Lab-
Tex chamber slides (Sigma-Alderich) as we described previously
[24]. Briefly, cells were fixed by incubating slides in methanol for
10 min followed by acetone for 5 min at 220uC. Afterwards,
slides were rinsed three times for 5 min each at ambient
temperature in PBS containing 0.05% v/v Tween-20 (PBS-T).
Slides were then blocked for 30 min at ambient temperature in
PBS-T containing 1% w/v BSA. Rat anti-CD8a (clone 53–6.7,
eBioscience, San Diego, CA), rat anti-CD4 (clone Gk1.5,
eBioscience), rat anti-CD8b (clone YTS156.7.7, BioLegend), and
hamster anti-CD11c (clone HL3, BD Biosciences) were used for
IHC. Immunostaining was done using CD11c/CD4, CD11c/
CD8a, or CD11c/CD8b antibody combinations and staining for
1 h at 25uC. After three rinses for 5 min each in PBS, slides were
incubated for 1 h at 25uC with secondary antibodies labeled with
anti-hamster FITC or anti-Rat TRITC (Invitrogen). Slides were
washed three times with PBS, air-dried and mounted with Prolong
Gold DAPI mounting medium (Invitrogen). Images were captured
at 102461024 pixels (original magnification = 20X) in indepen-
dent fluorescence channels using a Nikon C1 eclipse inverted
confocal microscope.
DNA Extraction and PCR Analysis for HSV-1 Genomic
DNA
DNA was isolated from homogenized individual TG using the
commercially available DNeasy Blood &Tissue Kit (Qiagen,
Stanford, CA) according to the manufacturer’s instructions. PCR
analyses were done using gB specific primers (Forward - 59-
AACGCGACGCACATCAAG-39; Reverse - 59-CTGGTACGC-
GATCAGAAAGC-39; and Probe - 59-FAM-CAGCCGCAG-
TACTACC-39). The amplicon length for this primer set was
72 bp. Relative copy numbers for gB DNA were calculated using
standard curves generated from the plasmid pAc-gB1. In all
experiments, GAPDH was used for normalization of transcripts.
RNA Extraction, cDNA Synthesis, and TaqMan RT-PCR
RNA was extracted from latent TG or infected DCs as we have
described previously [24–26]. Following RNA extraction, 1 mg of
total RNA was reverse-transcribed using random hexamer primers
and Murine Leukemia Virus (MuLV) Reverse Transcriptase from
the High Capacity cDNA Reverse Transcription Kit (Applied
Biosystems, Foster City, CA), in accordance with the manufac-
turer’s recommendations. The levels of various transcripts were
evaluated using commercially available TaqMan Gene Expression
Assays (Applied Biosystems) with optimized primer and probe
concentrations. Primer-probe sets consisted of two unlabeled PCR
primers and the FAM
TM
dye-labeled TaqMan MGB probe
formulated into a single mixture. Additionally, all cellular
amplicons included an intron-exon junction to eliminate signal
Figure 4. LAT and gB levels in latently-infected CD8a2/2 mice
following adoptive transfer of bone marrow or CD3+CD8+ T
cells. Each recipient CD8a2/2 mice received bone marrow (BM) or
CD3+CD8+ T cells as described in Materials and Methods. Control mice
did not receive adoptive transfer. Two weeks post-transfer, mice were
ocularly infected as described in Materials and Methods. Quantitative
RT-PCR and PCR was performed on RNA and DNA isolated from the TG
of surviving mice to determine copy number of the LAT or gB
transcripts, respectively. Each data point represents the mean 6 SEM
from 14 TGs. Panels: A) LAT RNA; and B) gB DNA.
doi:10.1371/journal.pone.0093444.g004
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Figure 5. CD8a+ DCs in BXH2 mice. A) FACS. Subconfluent monolayers of DCs from WT C3H/HEJ and BXH2/TyJ mice were grown to confluency
and stained with anti-CD8a antibody and analyzed by FACS. Left panel show expression of CD8a+ DCs in WT mice, while the right panel shows CD8a+
DCs in BXH2 mice. Number above each box indicates the percent of CD8a+ DCs per mouse strain. B) IHC. BM-derived DCs from BXH2 mice were
Role of CD8a DCs in HSV-1 Latency
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from genomic DNA contamination. The HSV-1 gB and LAT
primers and probe used were as follows: 1) gB: forward primer, 59-
AACGCGACGCACATCAAG-39, reverse primer, 59-
CTGGTACGCGATCAGAAAGC-39; and probe, 59-FAM-
CAGCCGCAGTACTACC-39 – Amplicon length = 72 bp; and
2)LAT: forward primer 59-GGGTGGGCTCGTGTTACAG-39;
reverse primer, 59-GGACGGGTAAGTAACAGAGTCTCTA-
39; and probe, 59- FAM-ACACCAGCCCGTTCTTT-39– Am-
plicon Length = 81 bp, corresponding to LAT nts 119553–
119634. As an internal control, a set of GAPDH primers from
Applied Biosystems (ASSAY I.D. m999999.15_G1 - Amplicon
Length = 107 bp) was used.
Quantitative real-time PCR (qRT-PCR) was performed using
an ABI PRISM 7900HT Sequence Detection System (Applied
Biosystems, Foster City, CA) in 384-well plates as we described
previously [25,26]. Real-time PCR was performed in triplicate for
each tissue sample. The threshold cycle (Ct) values, which
represents the PCR cycle at which there is a noticeable increase
in the reporter fluorescence above baseline, were determined using
SDS 2.2 Software. GAPDH transcript was used for normalization
purposes.
Statistical Analysis
Student’s t test and chi-squared tests were performed using the
computer program Instat (GraphPad, San Diego). Results were
considered statistically significant when the P value was ,0.05.
Results
Effect of CD8 T Cells on the Establishment of Latency in
Latently Infected Mice
It was now generally accepted that CD8 T cells play a dominant
role to maintain HSV-1 latency [11]. We ocularly infected WT
C57BL/6, C57BL/6-b2m
2/2, and C57BL/6-CD8a2/2 mice
with 26105 PFU/eye of WT HSV-1 strain McKrae. C57BL/6-
CD8a2/2 mice are devoid of CD8+ T cells, and C57BL/6-b2m
2/
2 mice lack functional CD8+ T cells due to the absence of major
histocompatibility complex I (MHC-I). Individual TG from
surviving mice were isolated on day 28 post-infection (PI), and
total DNA was prepared. TaqMan PCR was performed as
described in Materials and Methods to quantitate viral gB DNA as
a measure of HSV-1 genome copies and hence, latency. The
combined data from two separate experiments are shown in
Figure 1.
Surprisingly, the amount of viral DNA during latency in WT
mice was similar to that of b2m
2/2 mice (Figure 1A; WT vs.
b2m
2/2; p = 0.9). This suggests that lack of MHC-I and functional
classical CD8 T cells does not impact viral latency but does not
rule out the involvement of non-classical T cells in latency as was
reported for gamma-herpesvirus 68 [27]. By contrast, gB copy
number in TG of CD8a2/2 mice was reduced at least 6-fold
compared to WT and b2m
2/2 mice (Figure 1A, P,0.0001 for
each comparison). These data demonstrate that the phenotype of
CD8a2/2 mice significantly differs from b2m
2/2 or WT mice
with regards to latency.
During HSV-1 neuronal latency, only the LAT transcript is
consistently expressed at high levels [28,29]. We next sought to
confirm our gB DNA latency results by quantitating LAT
expression levels. On day 28, TG from surviving mice were
harvested and LAT transcript was determined by TaqMan RT-
PCR from total RNA isolated from individual TG. The amount of
LAT RNA detected in the TG of b2m
2/2 mice was significantly
higher compared with WT mice (Figure 1B, p,.001). In
agreement with the gB DNA results (Figure 1A), TG from
CD8a2/2 mice had LAT copy numbers that were over 4 orders of
magnitude lower than WT or b2m
2/2 mice (Figure 1B, P,0.0001
for each comparison). These striking results demonstrate that
absence of CD8a, but not b2m, reduces HSV-1 latency.
CD8 consists of either aa homodimers or ab heterodimers [30].
To follow-up from our CD8a2/2mouse results, we next evaluated
whether CD8b impacted viral latency using CD8b2/2 mice.
CD8b2/2 and WT mice were ocularly infected as above, TG
were harvested on day 28 PI, and TaqMan PCR and RT-PCR
were performed as detailed above. Combined data from two
separate experiments are shown in Figure 2. The amount of
latency, as determined by viral DNA and LAT RNA, was similar
between CD8b2/2 and WT mice (Figure 2A and B; p.0.05).
Interestingly, absence of the CD8b chain did not affect latency.
CD8b2/2 mice have attenuated T cell function but normal
numbers of functional CD8a DCs [20]. These results raise the
possibility that CD8a DCs2rather than CD8 T cells2play the
primary role in HSV-1 latency establishment.
Nonetheless, lower latency in CD8a2/2 compared with WT,
b2m
2/2, or CD8b2/2 mice could be owed to absence of CD8a T
cells, CD8a DCs, or both. Mouse plasmacytoid DCs (pDCs) were
previously thought to express CD8a, but not CD8b. However, it
was recently shown that at least one DC subclass does express
CD8b [31]. To evaluate expression profiles of CD8a and CD8b
on DCs, BM-derived DCs from naive WT, b2m
2/2, CD8a2/2,
and CD8b2/2 mice were grown to confluency on chamber slides
as described in Materials and Methods. Cells were stained with
various combinations of CD11c, CD8a or CD8b antibodies, and
CD11c/CD4 immunostaining was used as a positive control for
each mouse strain. Immunohistochemistry (IHC) results are shown
in Figure 3. CD4, CD8a, and CD8b were all detected on DCs
isolated from WT and b2m
2/2 mice (Figure 3A, WT DCs; 3B,
b2m
2/2 DCs). By contrast, CD8a or CD8b DCs were not
detected on DCs isolated from CD8a2/2 mice, while CD4 DCs
were present (Figure 3C, CD8a2/2 DCs). These results are
consistent with a previous study showing that mouse CD8b cannot
be expressed as a bb homodimer in the absence of CD8a [32,33].
In contrast, CD8b2/2 mice lacked CD8b DCs, while CD8a DCs
were not affected (Figure 3D, CD8b2/2 DCs). Thus, these results
allow us to group pDCs into CD8a+b+, CD8a+b-, and CD8a-b-.
These data dovetail with a previous report showing distinct
populations of pDCs according to their surface expression of
CD8a or CD8b [31]. Taken together, these results suggest that
lack of CD8a DCs alone or in combination with CD8 T cells
reduces latency in CD8a2/2 mice compared with WT, b2m
2/2,
or CD8b2/2 mice.
Adoptive Transfer of CD8a DCs, but not CD8 T Cells,
Increases Latency in HSV-1-Infected CD8a2/2 Mice
In the above experiments using CD8a2/2 mice, we found
significantly reduced viral latency compared with WT, b2m2/2,
or CD8b2/2 mice. Therefore, it was of interest to determine if
isolated and grown on Lab-Tex chamber slides. At 24 hr post culture, DCs were fixed, stained with anti-CD11c/anti-CD8a or anti-CD11c/anti-CD8b
antibodies followed by incubation with relevant secondary antibody to each primary antibody as described in Materials and Methods. DAPI is shown
as a nuclear counter-stain. Upper panels from left to right DAPI, CD11c (FITC), CD8a (TRITC), and Merge; and bottom panels: from left to right DAPI,
CD11c (FITC), CD8b (TRITC), and Merge.
doi:10.1371/journal.pone.0093444.g005
Role of CD8a DCs in HSV-1 Latency
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decreased latency was due to attenuated CD8a DCs or CD8 T
cells. CD8a2/2 mice adoptively received either BM-derived
CD8a DCs or T cells from WT GFP mice as described in
Materials and Methods. Abundance of LAT RNA in mice that
received BM-derived CD8a DCs was at least 6-fold higher than in
mice that received CD8 T cells or no adoptive transfer (Figure 4A;
BM DC transfer vs. no transfer or CD8 T cell transfer; p,0.0001).
There was no difference in latency between mice that received
CD8 T cells and no transfer control mice (Figure 4A, p.0.05). A
similar pattern of results was observed when latency levels were
judged by gB DNA (genomic DNA) levels (Figure 4B). Thus,
adoptive transfer of BM-derived CD8a DCs significantly increased
the levels of LAT and gB DNA in CD8a2/2 mice, while transfer
of CD8 T cells had no effect. Figure S1A and S1B shows detection
of GFP+CD8a+ T cells or GFP+CD8a+ DCs in the TG, BM, and
spleen of recipient mice both before infection and at 14 and 28
days PI. Figure S1C shows the presence of GFP+CD8a+ T cells in
the spleen, thymus and TG of ocularly infected mice on day 28 PI
via immunohistochemistry. In summary, these results indicate that
CD8a DCs, and not CD8 T cells, play an indispensable role in
increasing HSV-1 latency.
BXH2 Mice have Similar Viral Latency as CD8a2/2 Mice
Previously, it was shown that interferon regulatory factor 8
(IRF-8) is essential for the development of CD8a myeloid DCs and
pDCs [34]. More recently, a spontaneous point mutation was
identified in the IRF-8 gene in the BXHBXH2 mouse [35]. This
mutant has a similar phenotype as the IRF-8 knockout mouse, but
without impaired pDC development and these mice are compe-
tent to produce type 1 IFNs [16]. As shown in Figure 5A, DCs
isolated from BXH2 mice had no significant numbers of CD8a
DCs compared with C3H/HEJ control mice. IHC results also
confirmed the absence of CD8a as well as CD8b on these cells
(Figure 5B). These results are similar to a previous report by Tailor
et al showing that BXH2 mice do not have CD8a DCs but have
intact CD8 T cell responses [16]. Thus, similar to CD8a2/2 mice,
BXH2 mice lack CD8a DCs, but in contrast to CD8a2/2 mice,
they have normal CD8 T cells. To determine if the absence of
CD8a DCs, as opposed to CD8 T cells, contributed to higher
latency in the CD8a2/2 mouse, we ocularly infected BXH2 mice
with 26103 PFU/eye of HSV-1 strain McKrae. Control C3H/
HEJ mice were similarly infected. The amount of LAT RNA
detected in TG of BXH2 mice was significantly lower than control
C3H/HEJ mice (Figure 6A, p,0.001).
To further confirm the role of CD8a DCs in establishment of
viral latency, BXH2 mice adoptively received BM-derived CD8a
DCs from WT C3H/HEJ mice as described in Materials and
Methods. BXH2 untreated mice, BXH2 mice that received
CD8a+ DCs, and control C3H/HEJ mice were ocularly infected
with 26105 PFU/eye of avirulent HSV-1 strain KOS to reduce
death of infected animals. Abundance of LAT RNA in mice that
received BM-derived CD8a DCs was similar to control C3H/HEJ
mice, and both were significantly higher when compared to
untreated BXH2 mice (Figure 6B). Thus, adoptive transfer of
CD8a DCs recovers the phenotype of the BXH2 mice. These
results further bolster the notion that CD8a DCs2and not CD8 T
cells2function to increase viral latency.
Figure 6. Quantitation of latency in BXH2 mice infected with
HSV-1. A) Infection of mice with virulent HSV-1 strain McKrae. BXH2 or
wild-type (WT) C3H/HEJ mice were infected with 26103 PFU/eye of
virulent HSV-1 strain McKrae. Twenty eight days PI, TGs from infected
mice were harvested and quantitative RT-PCR was performed on each
individual mouse TG as described in Materials and Methods. Each data
point represents the mean 6 SEM from 18 or 12 TGs from BXH2 or WT
mice from two separate experiments. B) Latency following adoptive
transfer of CD8a DCs. Each recipient BXH2 mouse received BM-derived
CD8a DCs from WT mice as described in Materials and Methods. A
subset of BXH2 mice did not receive adoptive transfer, as a negative
control. BM-derived recipient BXH2, untreated BXH2, and WT mice were
ocularly infected with 26105 PFU/eye of avirulent HSV-1 strain KOS.
Twenty-eight days PI, TG from infected mice were harvested and
quantitative RT-PCR were performed on each individual mouse TG. Each
data point represents the mean 6 SEM from 18 TG from BM-derived
recipient BXH2 or 16 TG from untreated BXH2 mice.
doi:10.1371/journal.pone.0093444.g006
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HSV-1 Infectivity is Reduced in DCs Isolated from CD8a2/
2 Mice
The above experiments suggested that absence of CD8a DCs
affected the level of latency in vivo. To determine if this effect also
operated in vitro, DCs were isolated and cultured from naive WT,
b2m
2/2, CD8b2/2, or CD8a2/2 mice. DCs were then infected
with 1 PFU/cell of HSV-1 strain McKrae, as described in
Materials and Methods. At 24 h PI, RNA was isolated and gB
transcript abundance was measured by qRT-PCR (Figure 7).
Similar to our results with knockout mice, infected CD8a2/2 DCs
had at least 10-fold less gB RNA than DCs from WT, b2m
2/2, or
CD8b2/2 mice (Figure 7, p,0.0001).
Discussion
One of the hallmarks of HSV infection is the ability of the virus
to establish latency in neurons of an infected host [36–38]. Once
acquired, latent infections demonstrate a lifelong pattern of
episodic recurrence, such that infected individuals serve as
permanent carriers who are intermittently infectious [7–9]. The
most efficient way to decrease latency and subsequent recurrent
infections is to reduce establishment of latency, thus decreasing the
probability of subsequent reactivations and recurrent eye disease.
Previously, we showed that lymphoid-related DCs enhance HSV-1
latency in TG of infected mice and that immunization of mice
with Flt3L, which increases lymphoid-related DCs, increases latent
virus in the TG [15,39].
DCs have been classified into several subsets based on their
immunophenotype, resident location, and functional differences
[40,41]. CD8a DCs are specialized cells known for cross-
presentation of antigens by MHC-I molecules and for their major
role in priming cytotoxic CD8 T cell responses in vivo [42–45]. In
addition, they have a high capacity to engulf apoptotic cells, which
are used as a source of antigens for cross-priming [46]. Human
blood DC antigen 3 (CD141, BDCA3) DCs are reported to be the
homologue of mouse CD8a DCs [47]. To elucidate whether a
relationship existed between CD8a DCs and HSV-1 latency, we
utilized a multitude of gene deficient murine models. In this
report, we show that increased viral latency is determined by
CD8a DCs, but not CD8 T cells. Interestingly, we previously
reported increased latency in CD42/2 mice, indicating the
importance of CD4 T cells in orchestrating immune responses
against HSV-1 latency [39].
In contrast to CD8a+ DCs, CD8a- DCs preferentially drive
activation of CD4 T cells [48], can produce IFNs and IL-12 [49],
acquire the ability to cross-present antigen [50], and induce CD4
cytotoxic regulatory T cells [51–54]. In addition, CD8a- DCs are
more effective than CD8a+ DCs at activating antigen-specific
CD4 T cells [43,55]. On the other hand, cross-presenting self-Ags
is unique to CD8a+ DCs, and is either completely absent or less
effective in other DC subsets [56]. However, the cross-presentation
capacity of CD8a+ DCs is a double-edged sword, as it also
increases their susceptibility to infection [57,58]. Consequently,
infected CD8a+ DCs may lose their function and/or block the
APC function of other DC subtypes. This may lead to greater viral
latency and loss of CD8 T cell function. Thus, lower latency in the
absence of CD8a+ DCs, as found in this report, may be due to
APC subtypes other than CD8a+ DCs being able to process
Figure 7. Replication of HSV-1 in bone marrow-derived DCs. Sub-confluent monolayers of DCs cultured from WT, b2m
2/2, CD8b2/2, or
CD8a2/2 mice were infected with 1 PFU/cell of HSV-1 strain McKrae for 24 h as described in Materials and Methods. RNA was isolated and the
amount of gB transcript was determined by Taq-Man RT-PCR and normalized to GAPDH DNA. Each data point represents the mean 6 SEM (n= 4).
doi:10.1371/journal.pone.0093444.g007
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antigen and induce a more effective antiviral response. Consistent
with this notion, absence of CD8a+ DCs in mice enhances
resistance to the intracellular bacterium Listeria monocytogenes [58].
These results are also consistent with reports on the negative role
of certain DC populations in control of Vaccinia virus [59], HIV-1
[60,61], and dengue virus [62]. In addition, the potential for
autoimmunity induced by DCs, particularly in response to
persistent viral infection, has been suggested by others [63].
Because of the critical role that DCs play in orchestrating
immune responses, there is increasing interest in using signals that
are known to activate DCs to stimulate and improve vaccine
efficacy. However, the negative aspects of DCs have received far
less attention than their positive roles, likely due to enthusiasm for
their immunotherapeutic potential (reviewed in [64]). It was
shown that Langerhans cells are negative regulators of the anti-
Leishmania response in mice [65], similar to our results reported
here for CD8a DCs and HSV-1. Additionally, Vaccinia virus
abortively infects both mature and immature DCs and blocks their
maturation; hence, T cell activation is impaired [59]. By inhibiting
maturation pathways in DCs and inducing their death, Vaccinia
virus can subvert the development of efficient antiviral T cell
immunity. Similarly, we found here that DCs isolated from
CD8a2/2 mice harbor fewer viruses than other populations of
DCs. Consequently, HSV-1 infected DCs may directly, or via a
negative feedback control mechanism, interfere with DC function,
thus inhibiting induction of antiviral responses leading to even
higher latency. Previously, it was shown that depletion of DCs
during primary ocular infection reduces NK cells function and
results in impaired clearance of HSV-1 from the eye of infected
mice [66]. Maturation of DCs is required to induce potent
immune responses, and HSV-1 infection elicits immune responses
incapable of preventing or eradicating infection. Furthermore, we
have previously shown that mature murine DCs can be infected by
HSV-1, but the virus does not replicate in infected DCs [24].
Similarly, it was shown that following infection with HSV-1,
immature DCs generate infectious viral particles, while mature
DCs do not support virus production [67]. Finally, HSV-1
infection of human DCs results in functional impairment of the
infected cells [68–70].
It has been shown that TG-resident CD8 T cells block HSV-1
reactivation from latency, and that these cells are necessary for
maintaining viral latency [11,12]. Additionally, CD8 T cells can
actively suppress viral reactivation through release of IFN-c [71].
It was reported that adding anti-CD8 antibody to cells isolated
from TG of latently infected mice increases reactivation of latent
virus [11]. Interestingly however, these studies all relied on CD8a
antibody, and so their results might be reinterpreted as implicating
CD8a DCs as opposed to CD8 T cells.
A key finding in our study is that increased latency is due to
CD8a+ DCs. These results might also translate into neuroprotec-
tion, since increased latency usually means more neurons survive
the primary infection. Along these lines, our published studies have
shown that transfer of CD11c+CD8a+ cells significantly enhances
latency in the TG of WT infected mice, whereas transfer of
CD11c+CD8a- cells reduces latency [39].
Overall, our results suggest that CD8a+ DCs, rather than CD8+
T cells, play a non-redundant role in increasing HSV-1 latency.
Thus, we propose that infection of CD8a+ DCs by HSV-1 reduces
the antiviral response, resulting in greater latency, which in turn
leads to increased recruitment of CD8 T cells at the site of latent
infection. Continuous exposure of these CD8 T cells to viral
antigens results in increased PD-1/PD-L1 and T cell exhaustion as
we reported recently [13]. Our results reveal a previously
unappreciated role of innate immunity in maintaining HSV-1
latency.
Conclusion
Previously, it was reported that CD8+ T cells infiltrate
trigeminal ganglia (TG) at the time of latency establishment and
contributing to increase of latency as well as inhibiting HSV-1
reactivation from latency. This has become the standard
mechanism of HSV-1 latency-reactivation among herpes research-
ers. To determine factors that are contributing to increase of
latency, we examined latency in TG of WT mice versus CD8a2/2
and BXH2 mice, both of which lack CD8a DCs but CD8a2/2
mice lack CD8+ T cells, while BXH2 mice have CD8+ T cells.
Additionally, b2m2/2 and CD8b2/2 mice that have CD8a DCs
were utilized. Overall, we report here that, in the absence of
CD8a+ DCs, HSV-1 latency was significantly decreased in vivo.
Thus, these studies point to a key role for CD8a+ DCs rather than
CD8+ T cells in establishment and maintenance of HSV-1 latency
in TG of infected mice.
Supporting Information
Figure S1 Efficiency of adoptive CD8a+ T cells or BM to
recipient CD8a2/2 mice. Naive CD8a+ T cells or BM were
isolated from naive C57BL/6-GFP+ mice as described in Materials
and Methods. Isolated CD8a+ T cells or BM were transferred IP
or IV into recipient CD8a2/2 mice, respectively. Two weeks post
transfer some of the recipient mice were infected ocularly with
26105 PFU/eye of WT HSV-1 strain McKrae. On day 14 before
ocular infection and on days 14 and 28 PI some of the mice were
euthanized and the presence of GFP+ cells in TG, BM, spleen and
thymus were determined by FACS and IHC. A) Transfer of
CD8a+GFP+ T cells to recipient mice. Presence of total GFP+ cells
in TG, BM, and spleen of donor WT-GFP+ mice are shown as
control in the left side under the WT-GFP column. Marked area
inside each quadrant show presence of CD8a+GFP+ T cells in TG,
BM, and spleen of recipient mice before and after infection; B)
Transfer of BM-GFP+ cells to recipient mice. Marked area inside
each quadrant show presence of GFP+ in TG, BM, and spleen of
recipient mice before and after infection; and C) Detection of
CD8a+GFP+ T cells in recipient mice. Presence of CD8a+GFP+ T
cells in TG, thymus, and spleen of recipient mice were determined
by IHC using anti-GFP-488 antibody to enhance the signal. DAPI
is shown as a nuclear counter-stain. Spleen (upper panels): from
left to right DAPI, anti-GFP-488, and Merge; Thymus (middle
panels): from left to right DAPI, anti-GFP-488, and Merge; and
TG (Bottom): from left to right DAPI, anti-GFP-488, and Merge.
(PPT)
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